Evaluation of neurofibromatosis type 1 progression using a nationwide registry of patients who submitted claims for medical expense subsidies in Japan between 2008 and 2012

DOI: 10.1186/s13023-019-1148-8

Keywords: Intractable rare disease, Neurofibromatosis type 1, Progression, Follow-up, National registry, Medical expense subsidies, Japan

Full-Text   Cite this paper   Add to My Lib

Abstract:

The online version of this article (10.1186/s13023-019-1148-8) contains supplementary material, which is available to authorized users

Full-Text